Addus HomeCare (NASDAQ:ADUS) Given New $150.00 Price Target at Oppenheimer

Addus HomeCare (NASDAQ:ADUS) had its price target hoisted by Oppenheimer from $145.00 to $150.00 in a research note issued to investors on Friday,Benzinga reports. Oppenheimer currently has an outperform rating on the stock.

Several other equities research analysts have also recently weighed in on ADUS. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday. JMP Securities started coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 price target for the company. Stephens increased their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Finally, Macquarie reaffirmed an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $134.22.

Addus HomeCare Stock Performance

ADUS stock opened at $130.62 on Friday. Addus HomeCare has a 52 week low of $85.94 and a 52 week high of $136.72. The firm’s fifty day moving average is $126.10 and its 200 day moving average is $126.96. The firm has a market cap of $2.37 billion, a P/E ratio of 29.89, a P/E/G ratio of 1.73 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.03 EPS. As a group, analysts forecast that Addus HomeCare will post 4.58 EPS for the current year.

Insider Activity at Addus HomeCare

In related news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,750 shares of company stock valued at $4,930,750 in the last three months. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

A number of institutional investors and hedge funds have recently bought and sold shares of ADUS. Point72 Asset Management L.P. increased its stake in Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares in the last quarter. Millennium Management LLC increased its stake in Addus HomeCare by 412.7% during the 2nd quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock valued at $36,739,000 after purchasing an additional 254,705 shares in the last quarter. Wasatch Advisors LP increased its stake in Addus HomeCare by 11.8% during the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after purchasing an additional 110,010 shares in the last quarter. Ghisallo Capital Management LLC bought a new stake in Addus HomeCare during the 2nd quarter valued at about $11,611,000. Finally, Principal Financial Group Inc. increased its stake in Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after purchasing an additional 75,409 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.